Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Allocating funds toward an emergency reserve within a zero based budget creates resilience against unexpected costs and reduces stress.
20,206 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
In 2026, investors face a choice between steady large-cap growth and the higher upside (and volatility) of small-cap ...
A disciplined, theme-driven ETF approach can produce returns that exceed typical expectations. Learn how to recognize...
Solstice Advanced Materials and SiTime were added to the S&P MidCap 400 during the March 2026 quarterly rebalance, un...
Oil markets are volatile and opportunity-filled. This guide explains why here's prices surging right and shows practi...
Oil markets can surge, and prices near $100 tempting headlines pull investors toward energy stocks. This article expl...
Investors are watching Paysign as it tees up Q1 2026 earnings. This article breaks down what to expect, key metrics t...
As inflation climbs, retirees wonder what the 2027 Social Security COLA will be. This guide breaks down the latest pr...
A divorced retiree learns, at age 64, that she can claim up to 50% of her ex-spouse's Social Security record, lifting...
A rare moment in tech investing brings a high-quality name into focus. This article explains why Microsoft may be a o...
A landmark $1.5 billion bet on counter-drone tech sets Motorola Solutions up for deeper public-safety leadership. Her...
Miami-based fintech Karta just locked in a $15 million Series A and a $125 million debt facility to broaden its Whats...